145 related articles for article (PubMed ID: 12363175)
1. NEJM study detailing the causative link between ephedra-containing supplements and adverse cardiovascular and neurovascular.
Wolf L; Wolf M; Snavely M; Staudenmeier JJ;
Mil Med; 2002 Sep; 167(9):ii. PubMed ID: 12363175
[No Abstract] [Full Text] [Related]
2. Ephedra banned.
Cockey CD
AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
[No Abstract] [Full Text] [Related]
3. The relative safety of ephedra compared with other herbal products.
Kalman DS; Antonio J; Kreider RB
Ann Intern Med; 2003 Jun; 138(12):1006; author reply 1006-7. PubMed ID: 12809464
[No Abstract] [Full Text] [Related]
4. Psychosis related to ephedra-containing herbal supplement use.
Walton R; Manos GH
South Med J; 2003 Jul; 96(7):718-20. PubMed ID: 12940331
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of ephedra.
Ness J
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
[No Abstract] [Full Text] [Related]
6. Cardiovascular effects of ephedra.
Krantz MJ
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069036
[No Abstract] [Full Text] [Related]
7. Psychiatric symptoms associated with ephedra use.
Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P
Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450
[TBL] [Abstract][Full Text] [Related]
8. "Ephedra-free" diet pill-induced psychosis.
Retamero C; Rivera T; Murphy K
Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
[No Abstract] [Full Text] [Related]
9. More evidence supporting the ban of ephedra dietary supplements.
Chavez ML
Ann Pharmacother; 2004 May; 38(5):895-7. PubMed ID: 15044656
[No Abstract] [Full Text] [Related]
10. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
11. Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.
Milic M; Rizos D; Ziegler MG
JAMA; 2005 Sep; 294(12):1487; author reply 1487-8. PubMed ID: 16189358
[No Abstract] [Full Text] [Related]
12. Herbal supplements may require modifications of dental treatment.
Abebe W
Dent Today; 2009 Jan; 28(1):136-7. PubMed ID: 19323340
[No Abstract] [Full Text] [Related]
13. Adverse events associated with supplements containing ephedra alkaloids.
Geiger JD
Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
[No Abstract] [Full Text] [Related]
14. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
15. Time to ban ephedra--now.
Guharoy R; Noviasky JA
Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759
[No Abstract] [Full Text] [Related]
16. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers.
Gardner SF; Franks AM; Gurley BJ; Haller CA; Singh BK; Mehta JL
Am J Cardiol; 2003 Jun; 91(12):1510-3, A9. PubMed ID: 12804749
[No Abstract] [Full Text] [Related]
17. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
18. Natural-born killers.
Mandavilli A
Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
[No Abstract] [Full Text] [Related]
19. Ephedra/ephedrine: cardiovascular and CNS effects.
Wooltorton E; Sibbald B
CMAJ; 2002 Mar; 166(5):633. PubMed ID: 11898947
[No Abstract] [Full Text] [Related]
20. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
Haller CA; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2005 Jun; 77(6):560-71. PubMed ID: 15961987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
